- Home
- IKT vs SPPP Comparison
IKT vs SPPP Comparison
Compare IKT & SPPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- SPPP
- Stock Information
- Founded
- IKT 2008
- SPPP 2011
- Country
- IKT United States
- SPPP Canada
- Employees
- IKT N/A
- SPPP N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- SPPP
- Sector
- IKT Health Care
- SPPP
- Exchange
- IKT Nasdaq
- SPPP NYSE
- Market Cap
- IKT 168.0M
- SPPP 172.2M
- IPO Year
- IKT 2020
- SPPP N/A
- Fundamental
- Price
- IKT $2.00
- SPPP $9.74
- Analyst Decision
- IKT Buy
- SPPP
- Analyst Count
- IKT 2
- SPPP 0
- Target Price
- IKT $8.00
- SPPP N/A
- AVG Volume (30 Days)
- IKT 113.6K
- SPPP 183.3K
- Earning Date
- IKT 05-14-2025
- SPPP 01-01-0001
- Dividend Yield
- IKT N/A
- SPPP N/A
- EPS Growth
- IKT N/A
- SPPP N/A
- EPS
- IKT N/A
- SPPP N/A
- Revenue
- IKT N/A
- SPPP N/A
- Revenue This Year
- IKT N/A
- SPPP N/A
- Revenue Next Year
- IKT N/A
- SPPP N/A
- P/E Ratio
- IKT N/A
- SPPP N/A
- Revenue Growth
- IKT N/A
- SPPP N/A
- 52 Week Low
- IKT $1.12
- SPPP $8.55
- 52 Week High
- IKT $4.20
- SPPP $11.39
- Technical
- Relative Strength Index (RSI)
- IKT 46.57
- SPPP 59.69
- Support Level
- IKT $1.78
- SPPP $9.50
- Resistance Level
- IKT $2.13
- SPPP $9.51
- Average True Range (ATR)
- IKT 0.16
- SPPP 0.10
- MACD
- IKT -0.01
- SPPP 0.03
- Stochastic Oscillator
- IKT 37.61
- SPPP 96.67
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.